Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
Does fondaparinux provide effective anticoagulation in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids?
Fondaparinux may serve as an effective alternative anticoagulant for pregnant women at high risk of VTE who are intolerant to LMWH and heparinoids.
Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids -
Zotz et al. (Mon,) conducted a other in Venous thromboembolism in pregnancy. Fondaparinux was evaluated. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.